Hormone Signaling

Kisspeptin-10

Not FDA approvedGH axis & hormones
6.4/10

BioHarmony verdict

Worth trying

Kisspeptin-10 is an investigational reproductive neuropeptide that activates the HPG axis through the KISS1R receptor. Single subcutaneous kisspeptin-54 triggered egg maturation in 95 percent of women at high OHSS risk, per Abbara 2015, but kisspeptin-10 itself has thin direct human data and a minutes-long half-life.

Read full report

What is Kisspeptin-10?

Kisspeptin-10 is the master upstream switch for the reproductive axis, and that is the cleanest way to understand why it scores where it does. It is the minimal active fragment of kisspeptin, the natural signal that turns the whole hypothalamic-pituitary-gonadal system on. It activates the KISS1R receptor on GnRH neurons, which fire and drive the pituitary to release LH and FSH, which in turn drive your own testosterone or estradiol and gamete production. People born with a broken version of this receptor never enter puberty, which is the strongest proof you can get that this pathway is genuinely central, per Seminara 2003.

From the BioHarmony report, reviewed 2026-09-08.

How it is thought to work

Agonist at KISS1R (GPR54) on GnRH neurons, driving pulsatile GnRH, then LH and FSH

Safety watch-outs

  • Falling libido or hormone markers on continuous dosing, a sign of axis downregulation: stop and let the axis recover.
  • Any active or hormone-sensitive cancer, or reproductive cancer history: do not use, no safety data.
  • Pregnancy or attempting natural conception outside a supervised fertility setting: do not use.
  • Unverified or research-chemical source with no purity or identity testing: do not inject.

Full risk profile in the BioHarmony report.

Dosing as published

No approved-label or study protocol is recorded for Kisspeptin-10 yet.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Educator coverage (1)

Attributed viewpoints, separate from primary research.

Trust & sourcing

US approvalNot FDA approved
CompoundingFDA Category 2 for 503A use
Last checked2026-07-13
Next review2026-10-11

FDA places kisspeptin-10 in 503A Category 2 and says available safety information is insufficient to determine whether proposed compounded routes would cause harm.

Primary sources

  1. 7.5/10TB-500 (Thymosin Beta-4 Fragment)Strong recommendRecoveryNot FDA approvedTB-500 is a synthetic LKKTETQ fragment marketed for soft-tissue repair, but most human evidence is on full-length topical thymosin beta-4: Sosne 2023 reported corneal…
  2. 6.3/10Gonadorelin (GnRH)Worth tryingGH & hormonesFDA-approved product existsGonadorelin is synthetic GnRH, a decapeptide that tells the pituitary to release LH and FSH.
  3. 6.2/10IpamorelinWorth tryingRecoveryNot FDA approvedIpamorelin is a selective growth-hormone secretagogue with strong receptor selectivity but almost no human efficacy data: its only completed human efficacy trial…
  4. 6.0/10TesamorelinWorth tryingWeight & metabolicFDA-approved product existsTesamorelin is a stabilized GHRH analog that reduced visceral adipose tissue in the landmark Falutz 2007 HIV lipodystrophy Phase 3 trial and has newer support for…

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.